Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting

This study has been withdrawn prior to enrollment.
(Logistical difficulties running the study)
Sponsor:
Information provided by (Responsible Party):
Northwell Health
ClinicalTrials.gov Identifier:
NCT00699894
First received: June 16, 2008
Last updated: August 8, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: September 2008
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)